BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 26768027)

  • 1. Pathological criteria and practical issues in papillary lesions of the breast - a review.
    Ni YB; Tse GM
    Histopathology; 2016 Jan; 68(1):22-32. PubMed ID: 26768027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Papillary lesions of the breast - review and practical issues.
    Ni Y; Tse GM
    Semin Diagn Pathol; 2022 Sep; 39(5):344-354. PubMed ID: 35718581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Needle core biopsy can reliably distinguish between benign and malignant papillary lesions of the breast.
    Carder PJ; Garvican J; Haigh I; Liston JC
    Histopathology; 2005 Mar; 46(3):320-7. PubMed ID: 15720418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Papillary lesions of the breast.
    Ibarra JA
    Breast J; 2006; 12(3):237-51. PubMed ID: 16684322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraductal proliferations of the breast: a review of histologic criteria for atypical intraductal hyperplasia and ductal carcinoma in situ, including apocrine and papillary lesions.
    Purcell CA; Norris HJ
    Ann Diagn Pathol; 1998 Apr; 2(2):135-45. PubMed ID: 9845731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myoepithelial cells in solid variant of intraductal papillary carcinoma of the breast: a potential diagnostic pitfall and a proposal of an immunohistochemical panel in the differential diagnosis with intraductal papilloma with usual ductal hyperplasia.
    Moritani S; Ichihara S; Kushima R; Okabe H; Bamba M; Kobayashi TK; Hattori T
    Virchows Arch; 2007 May; 450(5):539-47. PubMed ID: 17377808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid papillary ductal carcinoma in situ versus usual ductal hyperplasia in the breast: a potentially difficult distinction resolved by cytokeratin 5/6.
    Rabban JT; Koerner FC; Lerwill MF
    Hum Pathol; 2006 Jul; 37(7):787-93. PubMed ID: 16784976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is core needle biopsy superior to fine-needle aspiration biopsy in the diagnosis of papillary breast lesions?
    Masood S; Loya A; Khalbuss W
    Diagn Cytopathol; 2003 Jun; 28(6):329-34. PubMed ID: 12768640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Papillary lesions of the breast: selected diagnostic and management issues.
    Collins LC; Schnitt SJ
    Histopathology; 2008 Jan; 52(1):20-9. PubMed ID: 18171414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of Papillary Breast Lesions on Core Needle Biopsy: Upgrade Rates and Interobserver Variability.
    Qiu L; Mais DD; Nicolas M; Nanyes J; Kist K; Nazarullah A
    Int J Surg Pathol; 2019 Oct; 27(7):736-743. PubMed ID: 31187678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of immunohistochemistry for smooth-muscle actin, p63, CD10 and cytokeratin 14 in the differential diagnosis of papillary lesions of the breast.
    Tse GM; Tan PH; Lui PC; Gilks CB; Poon CS; Ma TK; Law BK; Lam WW
    J Clin Pathol; 2007 Mar; 60(3):315-20. PubMed ID: 16698948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Papillomatous breast lesions with atypical columnar cell features.
    de Boer M; Verschuur-Maes AHJ; Moelans C; van Diest PJ
    J Clin Pathol; 2023 Apr; 76(4):228-233. PubMed ID: 36693714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Broad fibrovascular cores may not be an exclusively benign feature in papillary lesions of the breast: a cautionary note.
    Yamaguchi R; Tanaka M; Tse GM; Yamaguchi M; Terasaki H; Nomura Y; Takenaka M; Naito Y; Akiba J; Yano H
    J Clin Pathol; 2014 Mar; 67(3):258-62. PubMed ID: 24062357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Papillary lesions of the breast at percutaneous core-needle biopsy.
    Mercado CL; Hamele-Bena D; Oken SM; Singer CI; Cangiarella J
    Radiology; 2006 Mar; 238(3):801-8. PubMed ID: 16424237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathology of breast papillary neoplasms: Community hospital experience.
    Vdovenko AA
    Ann Diagn Pathol; 2020 Dec; 49():151605. PubMed ID: 32920473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of papillary lesions at percutaneous breast biopsy.
    Valdes EK; Tartter PI; Genelus-Dominique E; Guilbaud DA; Rosenbaum-Smith S; Estabrook A
    Ann Surg Oncol; 2006 Apr; 13(4):480-2. PubMed ID: 16474908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Papillary neoplasia of the breast: immunohistochemically defined myoepithelial cells in the diagnosis of benign and malignant papillary breast neoplasms.
    Raju UB; Lee MW; Zarbo RJ; Crissman JD
    Mod Pathol; 1989 Nov; 2(6):569-76. PubMed ID: 2479944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Papillary lesions of the breast.
    Kulka J; Madaras L; Floris G; Lax SF
    Virchows Arch; 2022 Jan; 480(1):65-84. PubMed ID: 34734332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast pathology practice: most common problems in a consultation service.
    Putti TC; Pinder SE; Elston CW; Lee AH; Ellis IO
    Histopathology; 2005 Nov; 47(5):445-57. PubMed ID: 16241992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectrum of Papillary Breast Lesions According to World Health Organization Classification of Papillary Neoplasms of Breast.
    Hashmi AA; Faraz M; Rafique S; Adil H; Imran A
    Cureus; 2020 Oct; 12(10):e11026. PubMed ID: 33214954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.